Guidance for Endo Pharmaceuticals Holdings Inc. (ENDP)
Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
---|---|---|---|---|---|---|
Q2 2022 | ($0.17) – ($0.15) | $0.48 | $550.00M – 525.00M | $655.60M | Lowered | Details |
Q1 2022 | $0.35 – $0.45 | $0.48 | $595.00M – 635.00M | $685.00M | = Maintained | Details |
2021 | $1.80 – $2.30 | $2.32 | $2.55B – 2.79B | $2.76B | = Maintained | Details |
2021 | $1.95 – $2.30 | $2.11 | $2.65B – 2.79B | $2.70B | = Maintained | Details |
2021 | $2.15 – $2.30 | $2.20 | $2.73M – 2.79M | $2.72M | = Maintained | Details |
2021 | N/A | N/A | $2.90B – 2.94B | $2.79B | = Maintained | Details |
Q1 2021 | $0.40 – $0.50 | $0.53 | $620.00M – 680.00M | $673.86M | = Maintained | Details |
2020 | $2.15 – $2.40 | $2.25 | $2.72B – 2.92B | $2.90B | = Maintained | Details |
2020 | $2.00 – $2.15 | $2.24 | $2.60B – 2.70B | $2.81B | Lowered | Details |
2020 | $2.50 – $2.55 | $2.14 | $2.75B – 2.80B | $2.70B | = Maintained | Details |
Q3 2020 | $0.08 – $0.13 | $0.37 | $515.00M – 550.00M | $626.90M | Lowered | Details |
2019 | $2.00 – $2.25 | $2.17 | $2.76B – 2.96B | $2.87B | = Maintained | Details |
2019 | $2.00 – $2.25 | $2.66 | $2.76B – 2.96B | $2.92B | Lowered | Details |
2019 | $2.10 – $2.25 | $2.17 | $2.86M – 2.89M | $2.87M | = Maintained | Details |
2018 | $2.15 – $2.55 | $2.86 | $2.60B – 2.80B | $3.03B | Lowered | Details |
2018 | $2.50 – $2.60 | $2.42 | $2.75B – 2.85B | $2.75B | = Maintained | Details |
2018 | $2.65 – $2.75 | $2.60 | $2.87B – 2.92B | $2.81B | Raised | Details |
Q2 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
2017 | $3.35 – $3.65 | $3.53 | $3.38B – 3.53B | $3.49B | = Maintained | Details |
Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q2 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
2016 | $5.85 – $6.20 | $6.02 | N/A | N/A | = Maintained | Details |
2016 | $4.50 – $4.80 | $5.69 | $3.87M – 4.03M | $4.29M | Lowered | Details |
2015 | $4.35 – $4.55 | $4.88 | $2.90B – 3.00B | $3.47B | = Maintained | Details |
2015 | $4.50 – $4.60 | $4.56 | $3.22B – 3.27B | $3.27B | = Maintained | Details |
2015 | $4.40 – $4.60 | $4.48 | $2.90B – 3.00B | $2.99B | = Maintained | Details |
2014 | $3.60 – $3.85 | $3.55 | $2.64B – 2.64B | $2.59B | = Maintained | Details |
2014 | $3.40 – $3.65 | $4.01 | $2.50B – 2.62B | $2.59B | = Maintained | Details |
2014 | $3.80 – $4.00 | $3.77 | N/A | N/A | Raised | Details |
2014 | $4.10 – $4.25 | $4.09 | $2.80B – 2.88B | $2.81B | Raised | Details |
2013 | $4.25 – $4.55 | $4.32 | $2.70B – 2.80B | $2.74B | = Maintained | Details |
2013 | $4.60 – $4.75 | $4.56 | $2.75B – 2.80B | $2.80B | Raised | Details |
2012 | $5.00 – $5.20 | $5.46 | $3.15B – 3.30B | $3.23B | = Maintained | Details |
2012 | $5.00 – $5.10 | $5.03 | $3.05B | $3.10B | = Maintained | Details |
2012 | N/A | N/A | $3.05B – 3.18B | $3.20B | Lowered | Details |
2011 | $4.20 – $4.30 | $3.17 | $2.35B – 2.45B | N/A | = Maintained | Details |